Atorvastatin Causes Insulin Resistance and Increases Ambient Glycemia in Hypercholesterolemic Patients
- 1 March 2010
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 55 (12), 1209-1216
- https://doi.org/10.1016/j.jacc.2009.10.053
Abstract
No abstract availableKeywords
Funding Information
- established investigator award
- Gachon University Gil Hospital
- Intramural Research Program, National Center for Complementary and Alternative Medicine, National Institutes of Health
This publication has 24 references indexed in Scilit:
- Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary AtherosclerosisDiabetes, 2009
- Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patientsAtherosclerosis, 2009
- Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes TrialsJournal of the American College of Cardiology, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trialsCurrent Medical Research and Opinion, 2008
- Simvastatin Improves Flow-Mediated Dilation but Reduces Adiponectin Levels and Insulin Sensitivity in Hypercholesterolemic PatientsDiabetes Care, 2008
- Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usageAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Additive Beneficial Effects of Fenofibrate Combined With Atorvastatin in the Treatment of Combined HyperlipidemiaJournal of the American College of Cardiology, 2005
- Statins and newly diagnosed diabetesBritish Journal of Clinical Pharmacology, 2004
- Inhibition by simvastatin, but not pravastatin, of glucose‐induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L‐type Ca2+ channels in rat islet β‐cellsBritish Journal of Pharmacology, 1999